
|Articles|August 20, 2018
Syneos Health Acquires Kinapse
Advertisement
Syneos Health, Inc., a biopharmaceutical solutions organization, announced the acquisition of Kinapse, a market advisory and operational solutions provider, from Hg, a specialist investor based in the U.K in order to further enhance end-to-end capabilities.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Approves Imfinzi Plus FLOT for Early and Locally Advanced Gastric and GEJ Cancers
2
Novo Nordisk Submits Higher-Dose Wegovy Injectable for FDA Approval with Priority Voucher
3
Is Artificial Intelligence Coming for Clinical Research?
4
FDA Clears Itvisma as First Gene Therapy for Adolescents and Adults With SMA
5






.png)



.png)



.png)
.png)
